Klaus Schollmeier is a businessperson who has been the head of 8 different companies. Presently, Dr. Schollmeier holds the position of Chairman for Anergis SA, Chairman of Pcovery ApS, Chairman for Eternygen GmbH, Chairman-Supervisory Board of Inthera Bioscience AG and Chairman for TACALYX GmbH. Dr. Schollmeier is also on the board of apceth Biopharma GmbH and CureVac NV.
Klaus Schollmeier previously occupied the position of Chairman & Investor Relations Contact at Santhera Pharmaceuticals Holding AG, Chief Executive Officer for SuppreMol GmbH, General Manager at BASF Pharma, Principal at Abbott GmbH (Germany), Principal at Knoll AG, Senior Director-Biotechnology at BASF Bioresearch Corp. and Research Associate Professor-Medical School at Boston University.
Klaus Schollmeier received a doctorate from Heinrich-Heine-Universitšt DŁsseldorf.